OpenVSafe by OpenVAERS
Search V-safe

VJR-25801-76755

2 vaccinations 2 coded responses 15 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
179 / PA
Registered
2021-09-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-09-20
    Registered in v-safe
  2. 2021-09-20
    Dose 1 — Pfizer-BioNTech
  3. 2021-09-20
    Health check-in — day 0, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  4. 2021-09-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness
    Adult check-in
  5. 2021-09-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-09-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-09-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-09-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-09-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-09-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-10-11
    Dose 2 — Pfizer-BioNTech
  12. 2021-10-11
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-10-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache
    Adult check-in
  14. 2021-10-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-10-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-10-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-10-25
    Survey response — day 14, dose 2
    MedDRA: Complication of pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Threatened miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-10-25
    Report sent to call center — day 14, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  19. 2021-10-27
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  20. 2022-01-14
    Survey response — 3 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Had second vaccine 10/12 had confirmed miscarriage 10/28
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-01-14
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  22. 2022-01-17

Vaccinations

DoseDateManufacturerCo-administered
12021-09-20Pfizer-BioNTech No
22021-10-11Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-10-25 Successful
2021-10-27
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-01-14 Unsuccessful

Free text

Release 10 — day 14, dose 2

2021-10-25

Symptoms: Threatened miscarriage

Release 10 — 3 months, dose 2

2022-01-14

Symptoms: Had second vaccine 10/12 had confirmed miscarriage 10/28

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDComplication of pregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release